Tulixone TZ 250mg/31.25mg Injection
Marketer
Tulip Lab Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Tulixone TZ 250mg/31.25mg Injection
Combiflox TZ injection (250mg/31.25mg) is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism inhibits microbial proliferation, thus controlling infection spread. Administration must be strictly under medical guidance; adhere to the prescribed dosage schedule. Complete the full course, even with symptom improvement; premature cessation may reduce efficacy. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Escalating side effects necessitate immediate medical attention. Seek emergency care for allergic reactions (rash, pruritus, edema, dyspnea). Disclose all current medications to your physician before commencing treatment, including any conditions. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving, avoid operation of vehicles if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and sufficient hydration are crucial for optimal recovery. Your doctor might order blood tests and other diagnostic procedures to monitor treatment effectiveness.
Primary Ingredients of Tulixone TZ 250mg/31.25mg Injection
No text was provided to rephrase. Please provide the text you wish to be rewritten.
Uses of Tulixone TZ 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Tulixone TZ 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Tulixone TZ 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Tulixone TZ 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Tulixone TZ 250mg/31.25mg Injection works:
Ceftriaxone/Tazobactam injection (Tulixone TZ 250mg/31.25mg) unites a cephalosporin antibiotic (Ceftriaxone) with a beta-lactamase inhibitor (Tazobactam). Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering their growth and survival. Tazobactam counters bacterial resistance mechanisms, thereby boosting Ceftriaxone's efficacy.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Tulixone TZ 250 mg/31.25 mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Tulixone TZ (250 mg/31.25 mg) is typically regarded as safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harm to offspring; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Tulixone TZ 250 mg/31.25 mg Injection to breastfeeding mothers requires careful consideration. It's recommended to discontinue breastfeeding for the duration of maternal treatment and until the medication is fully cleared from the mother's system.
DrivingUNSAFE
Administering Tulixone TZ 250 mg/31.25 mg Injection may induce drowsiness, visual disturbances, or dizziness. Driving is prohibited should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Tulixone TZ 250 mg/31.25 mg Injection to individuals with renal impairment. Seek medical advice.
LiverCAUTION
Administering Tulixone TZ 250 mg/31.25 mg Injection requires careful consideration in individuals with significant hepatic impairment; dosage modification may be necessary. Seek medical advice. Altering the Tulixone TZ 250 mg/31.25 mg Injection dosage is unnecessary for patients experiencing mild or moderate liver dysfunction.
What if you forget to take Tulixone TZ 250mg/31.25mg Injection :
Omit a scheduled Tulixone TZ 250 mg/31.25 mg Injection? Seek immediate medical advice.
Facts to Know About Tulixone TZ 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently